Live feed07:30:00·2089dPRReleasevia QuantisnowLeading Independent Proxy Advisory Firm ISS Recommends BridgeBio Pharma and Eidos Therapeutics Stockholders Vote “FOR” Proposed MergerByQuantisnow·Wall Street's wire, on your screen.EIDX· Eidos Therapeutics, Inc.BBIO· BridgeBio Pharma Inc.Health CareOriginal source
